Ion Exchange Reports Q2 Revenue of ₹6.74 Billion, Down YoY
Key highlights
- Ion Exchange reported Q2 FY27 consolidated revenue of ₹6.74 billion, compared with ₹7.34 billion a year earlier.
- The Q2 revenue decline was ₹0.60 billion, or approximately 8.2% year on year.
- Ion Exchange’s board approved unaudited Q2 and half-year FY27 results on November 3, 2026.
- Q1 FY27 consolidated net profit was ₹0.031 billion, down 93.6% year on year.
powered by IRIS

Ion Exchange (India) Limited reported Q2 FY27 consolidated revenue of ₹6.74 billion, down from ₹7.34 billion in the corresponding quarter a year earlier. The 8.2% year-on-year reduction puts focus on the company’s top-line performance after its board approved unaudited results for the quarter and half year ended September 30, 2026.
Know Ion Exchange (India) inside out
Results, valuation, peers and who's buying, in one view.
What did Ion Exchange report for Q2 FY27?
Ion Exchange reported Q2 consolidated revenue of ₹6.74 billion, compared with ₹7.34 billion in Q2 of the previous financial year. The difference of ₹0.60 billion represents a year-on-year decline of about 8.2%.
The reported comparison indicates that the company entered the second quarter with lower revenue than it generated in the equivalent period last year. Revenue is a closely watched measure for Ion Exchange because its operations span water and wastewater treatment, process-water solutions and related projects, where execution timing can influence quarterly recognition.
The supplied results summary identifies the figure as consolidated revenue. It therefore reflects the group-level performance reported by Ion Exchange rather than a standalone-company measure. No segment-wise revenue break-up, order inflow figure or reason for the year-on-year decline was provided in the available information.
When were the Q2 and half-year results approved?
Ion Exchange’s board of directors met on November 3, 2026, to consider and approve unaudited financial results for Q2 FY27 and the half year ended September 30, 2026. The meeting followed the company’s prior intimation to the exchanges regarding the planned consideration of these results.
The results cycle also included an earnings conference call. Ion Exchange corrected the call date in an October 29 announcement, setting it for November 5, 2026 at 2:00 p.m. IST. The earlier communication had carried October 5, 2026 as the call date, which the company subsequently clarified.
The company had approved its Q1 FY27 standalone and consolidated results at a board meeting held on August 5, 2026. Q1 consolidated operating income was reported at ₹7.005 billion, up 20.1% year on year, while consolidated net profit was ₹0.031 billion, down 93.6% year on year. This showed that revenue growth in the preceding quarter did not translate into comparable profit growth.
How does the Q2 revenue compare with recent performance?
Q2 revenue of ₹6.74 billion was lower than both the year-ago Q2 figure of ₹7.34 billion and the ₹7.005 billion operating income reported for Q1 FY27. The comparison with Q1 should be treated carefully because the supplied data labels the Q2 measure as consolidated revenue and the Q1 measure as consolidated operating income.
Still, the available numbers show a softer top line after Q1, when Ion Exchange reported revenue of about ₹7.0 billion. In Q1, the company’s profitability was also under pressure: operating EBITDA was ₹0.318 billion, down 49.3% year on year, while net profit was ₹0.031 billion and the reported PAT margin was 0.44%.
The combined pattern makes the Q2 revenue update relevant to investors tracking whether project execution and cost conditions are improving. However, the supplied Q2 material does not provide EBITDA, net profit, margin or earnings-per-share figures for the September quarter. Those metrics cannot be inferred from the revenue release alone.
Got a follow-up? Ask IRIS
What other matters are relevant for investors?
Ion Exchange said its Q2 and half-year results had an unmodified review report from Deloitte. An unmodified review report is a relevant disclosure in the results process, although it does not explain the movement in revenue or provide an outlook for future quarters.
Separately, the supplied information states that market regulator SEBI directed subsidiary Ion Exchange Enviro Farms to deposit ₹0.221 billion. An appeal before the Securities Appellate Tribunal is pending. This is a separate regulatory matter and the information provided does not link it to the Q2 revenue outcome.
Ion Exchange held its 62nd annual general meeting on September 11, 2026 through video conference. Shareholders approved four resolutions, including the adoption of audited standalone and consolidated financial statements and a dividend-related resolution, according to the provided event summary.
How could the Q2 update affect investors and operations?
The immediate market relevance of the update is the year-on-year decline in consolidated revenue. For investors, a fall from ₹7.34 billion to ₹6.74 billion places greater importance on subsequent disclosures about margins, order execution and the pace of business activity across the group.
The available data also shows why revenue alone is not sufficient to assess the company’s financial position. Ion Exchange’s Q1 FY27 operating income rose year on year, but its net profit fell sharply. Investors will therefore need to assess the full Q2 profit-and-loss statement, including operating profitability and finance costs, alongside the reported revenue.
A market snapshot in the supplied information showed Ion Exchange shares down 1.67%, but no date, closing price or direct reason for that movement was provided. It cannot therefore be attributed solely to the Q2 announcement. The scheduled earnings call is the disclosed forum where management may provide further context on the quarter.
Conclusion
Ion Exchange reported Q2 FY27 consolidated revenue of ₹6.74 billion, a decline of ₹0.60 billion from ₹7.34 billion in the year-ago quarter. The result follows a Q1 in which revenue growth was accompanied by substantial pressure on EBITDA and net profit, making the detailed September-quarter profitability figures important for a complete assessment.
The next disclosed event is Ion Exchange’s earnings conference call on November 5, 2026 at 2:00 p.m. IST. Investors will watch for management commentary on the Q2 revenue decline, margin performance, project execution and any update concerning the pending appeal involving Ion Exchange Enviro Farms.


